BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23821276)

  • 1. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
    Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
    Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of self-replicating subgenomic dengue virus 4 (DENV4) replicon.
    Alcaraz-Estrada SL; Del Angel R; Padmanabhan R
    Methods Mol Biol; 2014; 1138():131-50. PubMed ID: 24696335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of subgenomic replicons of New York strain of West Nile virus.
    Shi PY; Tilgner M; Lo MK
    Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
    Rossi SL; Zhao Q; O'Donnell VK; Mason PW
    Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication.
    Lo MK; Tilgner M; Bernard KA; Shi PY
    J Virol; 2003 Sep; 77(18):10004-14. PubMed ID: 12941911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential high-throughput assay for screening inhibitors of West Nile virus replication.
    Lo MK; Tilgner M; Shi PY
    J Virol; 2003 Dec; 77(23):12901-6. PubMed ID: 14610212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.
    Fayzulin R; Scholle F; Petrakova O; Frolov I; Mason PW
    Virology; 2006 Jul; 351(1):196-209. PubMed ID: 16647099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging.
    Pijlman GP; Kondratieva N; Khromykh AA
    J Virol; 2006 Nov; 80(22):11255-64. PubMed ID: 16971441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effects of alterations in the tick-borne encephalitis virus 3'-noncoding region on translation and RNA replication using reporter replicons.
    Hoenninger VM; Rouha H; Orlinger KK; Miorin L; Marcello A; Kofler RM; Mandl CW
    Virology; 2008 Aug; 377(2):419-30. PubMed ID: 18533218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
    Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA
    Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cis-acting elements in the rubella virus subgenomic RNA that play a role in its translation.
    Pappas CL; Tzeng WP; Frey TK
    Arch Virol; 2006 Feb; 151(2):327-46. PubMed ID: 16172842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triaryl pyrazoline compound inhibits flavivirus RNA replication.
    Puig-Basagoiti F; Tilgner M; Forshey BM; Philpott SM; Espina NG; Wentworth DE; Goebel SJ; Masters PS; Falgout B; Ren P; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1320-9. PubMed ID: 16569847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.
    Liu WJ; Chen HB; Wang XJ; Huang H; Khromykh AA
    J Virol; 2004 Nov; 78(22):12225-35. PubMed ID: 15507609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication.
    Ong SP; Choo BG; Chu JJ; Ng ML
    Antiviral Res; 2006 Dec; 72(3):216-23. PubMed ID: 16870272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA elements within the 5' untranslated region of the West Nile virus genome are critical for RNA synthesis and virus replication.
    Li XF; Jiang T; Yu XD; Deng YQ; Zhao H; Zhu QY; Qin ED; Qin CF
    J Gen Virol; 2010 May; 91(Pt 5):1218-23. PubMed ID: 20016034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening.
    Zhang HL; Ye HQ; Deng CL; Liu SQ; Shi PY; Qin CF; Yuan ZM; Zhang B
    Antiviral Res; 2017 May; 141():38-47. PubMed ID: 28202375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes.
    Varnavski AN; Khromykh AA
    Virology; 1999 Mar; 255(2):366-75. PubMed ID: 10069962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.